Tesamorelin
Growth Hormone · 10 mg fill · Research Peptide
A stabilised analogue of growth-hormone-releasing hormone, modified at the N-terminus.
Overview
Tesamorelin is a synthetic analogue of human growth-hormone-releasing hormone (GHRH 1-44), carrying a trans-3-hexenoic acid group at the N-terminus. That modification is the defining feature of the molecule: it slows enzymatic cleavage of the peptide chain relative to unmodified GHRH. As a research compound it is of interest for GHRH-receptor binding studies and for comparative work on how N-terminal conjugation changes the stability of a peptide analogue. Supplied lyophilized for laboratory research.
Specifications
- Form
- Lyophilized powder
- Vial size
- 10 mg
- Class
- GHRH (1-44) analogue, N-terminally conjugated
- Modification
- trans-3-hexenoic acid at the N-terminus
- Purity
- Stated on the batch COA
- Reconstitution
- Bacteriostatic water
- Storage
- Lyophilized: room temperature, protected from light, in the original carton
- Evidence base
- Published human clinical literature; supplied here for in-vitro research only
- Documentation
- Batch-specific COA on request
Research use
- GHRH-receptor binding and selectivity research
- N-terminal conjugation and peptide-stability studies
- Comparative GHRH-analogue research
- Enzymatic-degradation model systems
For research use only. This product is intended for laboratory and educational research purposes only. It is not made, labelled or sold as a drug, supplement or medical device, and it is not for human or veterinary consumption, diagnosis, treatment or cure of any condition. No dosing information is provided or implied. The molecule in this product is also the medicinal ingredient of a drug that has been authorized, or is under clinical investigation, in Canada or the United States; this product is not that drug, carries no drug identification number or marketing authorization, and is supplied solely for in vitro research.
Add to orderOpens it in the catalog so you can add it to your order.